Sadler Anthony J, Rossello Fernando J, Yu Liang, Deane James A, Yuan Xiangliang, Wang Die, Irving Aaron T, Kaparakis-Liaskos Maria, Gantier Michael P, Ying Hangjie, Yim Howard C H, Hartland Elizabeth L, Notini Amanda J, de Boer Suzan, White Stefan J, Mansell Ashley, Liu Jun-Ping, Watkins D Neil, Gerondakis Steve, Williams Bryan R G, Xu Dakang
MIMR-PHI Institute of Medical Research, Clayton, Victoria 3168, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia;
MIMR-PHI Institute of Medical Research, Clayton, Victoria 3168, Australia; Victorian Bioinformatics Consortium, Monash University, Clayton, Victoria 3800, Australia; Life Sciences Computation Centre, Victorian Life Sciences Computation Initiative, Parkville 3053, Australia;
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1535-40. doi: 10.1073/pnas.1409728112. Epub 2015 Jan 20.
Inflammation is critical for host defense, but without appropriate control, it can cause chronic disease or even provoke fatal responses. Here we identify a mechanism that limits the inflammatory response. Probing the responses of macrophages to the key sensory Toll-like receptors, we identify that the Broad-complex, Tramtrack and Bric-a-brac/poxvirus and zinc finger (BTB/POZ), transcriptional regulator promyelocytic leukemia zinc finger (PLZF) limits the expression of inflammatory gene products. In accord with this finding, PLZF-deficient animals express higher levels of potent inflammatory cytokines and mount exaggerated inflammatory responses to infectious stimuli. Temporal quantitation of inflammatory gene transcripts shows increased gene induction in the absence of PLZF. Genome-wide analysis of histone modifications distinguish that PLZF establishes basal activity states of early response genes to maintain immune homeostasis and limit damaging inflammation. We show that PLZF stabilizes a corepressor complex that encompasses histone deacetylase activity to control chromatin. Together with our previous demonstration that PLZF promotes the antiviral response, these results suggest a strategy that could realize one of the major goals of immune therapy to retain immune resistance to pathogens while curbing damaging inflammation.
炎症对于宿主防御至关重要,但如果没有适当的控制,它会导致慢性疾病甚至引发致命反应。在这里,我们确定了一种限制炎症反应的机制。通过探究巨噬细胞对关键传感Toll样受体的反应,我们发现广泛复合体、Tramtrack和Bric-a-brac/痘病毒和锌指(BTB/POZ)转录调节因子早幼粒细胞白血病锌指(PLZF)限制炎症基因产物的表达。与这一发现一致,PLZF缺陷动物表达更高水平的强效炎性细胞因子,并对感染性刺激产生过度的炎症反应。炎症基因转录本的时间定量显示,在没有PLZF的情况下基因诱导增加。全基因组组蛋白修饰分析表明,PLZF建立早期反应基因的基础活性状态以维持免疫稳态并限制有害炎症。我们表明,PLZF稳定了一个包含组蛋白脱乙酰酶活性以控制染色质的共抑制复合物。连同我们之前证明PLZF促进抗病毒反应,这些结果提出了一种策略,该策略可以实现免疫治疗的一个主要目标,即在抑制有害炎症的同时保留对病原体的免疫抗性。